Involved in Scientific Research? Then you must have heard about MA-based Thermo Fisher Scientific, Inc. (TMO - Free Report) , one of the leading scientific instrument manufacturers across the world. Interestingly for this acquisition-friendly company, the latest buy out of Life Technologies is expected to give birth to an unrivaled market leader serving research, Specialty Diagnostics and applied markets.
Currently, Thermo Fisher has a Zacks Rank #3 (Hold) but that could change following its impressive third-quarter 2016 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here). We have highlighted some of the key details from the just-released announcement below:
Earnings: The current Zacks Consensus Estimate is pegged at $1.97 per share. Thermo Fisher’s adjusted earnings per share of $2.03 beat this estimate by 3.04%.
Revenues: Thermo Fisher posted revenues of $4,490.9 billion, beating the Zacks Consensus Estimate for revenues of $4,392 billion.
Key Stats: Among its four business segments, Thermo Fisher delivered revenues of $1.23 billion (up 14%) in Life Sciences Solutions, $0.90 billion (up 15%) in Analytical Instruments, $0.80 billion (up 3%) in Specialty Diagnostics and $1.75 billion (up 7%) in Laboratory Products and Services respectively.
Major Factors: Thermo Fisher has raised its 2016 revenue guidance. Management seemed upbeat about the company’s acquisition of FEI, which is expected to add leading capabilities in electron microscopy that complement Thermo Fisher’s analytical instruments portfolio
Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.
Check back later for our full write up on this Thermo Fisher earnings report later!
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Involved in Scientific Research? Then you must have heard about MA-based Thermo Fisher Scientific, Inc. (TMO - Free Report) , one of the leading scientific instrument manufacturers across the world. Interestingly for this acquisition-friendly company, the latest buy out of Life Technologies is expected to give birth to an unrivaled market leader serving research, Specialty Diagnostics and applied markets.
Currently, Thermo Fisher has a Zacks Rank #3 (Hold) but that could change following its impressive third-quarter 2016 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here). We have highlighted some of the key details from the just-released announcement below:
Earnings: The current Zacks Consensus Estimate is pegged at $1.97 per share. Thermo Fisher’s adjusted earnings per share of $2.03 beat this estimate by 3.04%.
Revenues: Thermo Fisher posted revenues of $4,490.9 billion, beating the Zacks Consensus Estimate for revenues of $4,392 billion.
Key Stats: Among its four business segments, Thermo Fisher delivered revenues of $1.23 billion (up 14%) in Life Sciences Solutions, $0.90 billion (up 15%) in Analytical Instruments, $0.80 billion (up 3%) in Specialty Diagnostics and $1.75 billion (up 7%) in Laboratory Products and Services respectively.
Major Factors: Thermo Fisher has raised its 2016 revenue guidance. Management seemed upbeat about the company’s acquisition of FEI, which is expected to add leading capabilities in electron microscopy that complement Thermo Fisher’s analytical instruments portfolio
Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.
Check back later for our full write up on this Thermo Fisher earnings report later!
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on TMO - FREE